Control of Influenza

Overview

Journal Tex Heart Inst J

Specialty Cardiology & Vascular Diseases

Date 2004 Apr 6

PMID 15061625

Citations 2

Authors

W Paul Glezen

Affiliations

Soon will be listed here.

Abstract

Influenza is the classic emerging infection. Despite the availability of relatively inexpensive vaccines and specific treatments, influenza is the least controlled vaccine-preventable disease. Vaccination coverage of high-risk patients has improved, but all-cause mortality attributable to influenza continues to increase. A supplemental strategy is to vaccinate the principal disseminators of influenza in the community: school children and working adults. The availability of the live, attenuated, cold-adapted nasal spray vaccine should facilitate this goal.

Citing Articles

An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models.

Van Vlaenderen I, Van Bellinghen L, Meier G, Poulsen Nautrup B BMC Infect Dis. 2013; 13:25.

PMID: 23339290 PMC: 3570298. DOI: 10.1186/1471-2334-13-25.

Vaccinating to protect a vulnerable subpopulation.

Dushoff J, Plotkin J, Viboud C, Simonsen L, Miller M, Loeb M PLoS Med. 2007; 4(5):e174.

PMID: 17518515 PMC: 1872043. DOI: 10.1371/journal.pmed.0040174.

References

Monto A, DAVENPORT F, Napier J, FRANCIS Jr T . Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis. 1970; 122(1):16-25. DOI: 10.1093/infdis/122.1-2.16. View

Glezen W . Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis. 1980; 2(3):408-20. DOI: 10.1093/clinids/2.3.408. View

Nichol K, Lind A, Margolis K, Murdoch M, McFadden R, Hauge M . The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995; 333(14):889-93. DOI: 10.1056/NEJM199510053331401. View

Glezen W . Emerging infections: pandemic influenza. Epidemiol Rev. 1996; 18(1):64-76. DOI: 10.1093/oxfordjournals.epirev.a017917. View

Glezen W, Taber L, Frank A, Gruber W, Piedra P . Influenza virus infections in infants. Pediatr Infect Dis J. 1997; 16(11):1065-8. DOI: 10.1097/00006454-199711000-00012. View

Belshe R, Mendelman P, Treanor J, King J, Gruber W, Piedra P . The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998; 338(20):1405-12. DOI: 10.1056/NEJM199805143382002. View

Bernstein T, Brilli R, Jacobs B . Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis. 1998; 27(3):458-62. DOI: 10.1086/514681. View

Nichol K, Mendelman P, Mallon K, Jackson L, Gorse G, Belshe R . Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999; 282(2):137-44. DOI: 10.1001/jama.282.2.137. View

Neuzil K, Mellen B, Wright P, Mitchel Jr E, Griffin M . The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000; 342(4):225-31. DOI: 10.1056/NEJM200001273420401. View

10.

Izurieta H, Thompson W, Kramarz P, Shay D, Davis R, DeStefano F . Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000; 342(4):232-9. DOI: 10.1056/NEJM200001273420402. View

11.

Glezen W, Greenberg S, Atmar R, Piedra P, Couch R . Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000; 283(4):499-505. DOI: 10.1001/jama.283.4.499. View

12.

OBrien K, WALTERS M, Sellman J, Quinlisk P, Regnery H, Schwartz B . Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000; 30(5):784-9. DOI: 10.1086/313772. View

13.

Bridges C, Thompson W, Meltzer M, Reeve G, Talamonti W, Cox N . Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000; 284(13):1655-63. DOI: 10.1001/jama.284.13.1655. View

14.

Glezen W . Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine. 2001; 19 Suppl 1:S56-8. DOI: 10.1016/s0264-410x(00)00279-6. View

15.

Reichert T, Sugaya N, Fedson D, Glezen W, Simonsen L, Tashiro M . The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001; 344(12):889-96. DOI: 10.1056/NEJM200103223441204. View

16.

Kramarz P, DeStefano F, Gargiullo P, Chen R, Lieu T, Davis R . Does influenza vaccination prevent asthma exacerbations in children?. J Pediatr. 2001; 138(3):306-10. DOI: 10.1067/mpd.2001.112168. View

17.

Robinson P, Taylor K, Nolan T . Risk-factors for meningococcal disease in Victoria, Australia, in 1997. Epidemiol Infect. 2001; 127(2):261-8. PMC: 2869745. DOI: 10.1017/s0950268801005696. View

18.

Neuzil K, Hohlbein C, Zhu Y . Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med. 2002; 156(10):986-91. DOI: 10.1001/archpedi.156.10.986. View

19.

Thompson W, Shay D, Weintraub E, Brammer L, Cox N, Anderson L . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289(2):179-86. DOI: 10.1001/jama.289.2.179. View

20.

Nichol K, Mallon K, Mendelman P . Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine. 2003; 21(17-18):2207-17. DOI: 10.1016/s0264-410x(03)00029-x. View